NEW YORK (GenomeWeb) – Quest Diagnostics on Friday said that it expects revenues to grow 3 percent to 5 percent and earnings to grow in the mid- to high-single digits annually from 2017 to 2020.

The Madison, New Jersey-based firm also said it plans to raise its common stock dividend by more than 12 percent to an annual rate of $1.80 per share.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.